Skip to main content

Actinium Pharmaceuticals, Inc.

ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001388320

No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ATNM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders7269−3
Shares8.46M8.13M−325.2K (−3.8%)
Value$15.9M$10.2M−$5.65M (−35.6%)

New holders (14)

Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ATNM in Q4 2024
InstitutionSharesValue% of portfolio
SEI Investments Co49,214$62.0K0.00%
Vontobel Holding Ltd.25,000$31.5K0.00%
PFG Investments, LLC18,250$23.0K0.00%
Intech Investment Management LLC14,198$17.9K0.00%
Prospect Financial Services LLC12,400$15.6K0.01%
SG Americas Securities, LLC11,513$15.0K0.00%
Jain Global LLC10,831$13.6K0.00%
North Star Asset Management Inc10,000$12.6K0.00%
Police & Firemen's Retirement System of New Jersey7,915$9.97K0.00%
BNP Paribas Arbitrage, SA5,744$7.24K0.00%
Picton Mahoney Asset Management5,968$7.00K0.00%
Bank of Jackson Hole Trust1,000$1.26K0.00%
SBI Securities Co., Ltd.542$6830.00%
EverSource Wealth Advisors, LLC74$930.00%

Sold out (17)

Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.